ArticleClinicoEconomics and outcomes research : CEOR2019

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US.

Murtuza Bharmal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.